BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 9203528)

  • 1. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat.
    Widdowson PS; Upton R; Henderson L; Buckingham R; Wilson S; Williams G
    Brain Res; 1997 Nov; 774(1-2):1-10. PubMed ID: 9452185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.
    Dumont Y; Jacques D; Bouchard P; Quirion R
    J Comp Neurol; 1998 Dec; 402(3):372-84. PubMed ID: 9853905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
    Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
    Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoradiographic reevaluation of the binding properties of 125I-[Leu31,Pro34]peptide YY and 125I-peptide YY3-36 to neuropeptide Y receptor subtypes in rat forebrain.
    Gobbi M; Mennini T; Vezzani A
    J Neurochem; 1999 Apr; 72(4):1663-70. PubMed ID: 10098875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain.
    Widdowson PS
    Brain Res; 1993 Dec; 631(1):27-38. PubMed ID: 8298993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective tools to investigate neuropeptide Y receptors in the central and peripheral nervous systems: BIB03304 (Y1) and CGP71683A (Y5).
    Dumont Y; Cadieux A; Doods H; Fournier A; Quirion R
    Can J Physiol Pharmacol; 2000 Feb; 78(2):116-25. PubMed ID: 10737674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor.
    St-Pierre JA; Dumont Y; Nouel D; Herzog H; Hamel E; Quirion R
    Br J Pharmacol; 1998 Jan; 123(2):183-94. PubMed ID: 9489605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands.
    Dumont Y; Fournier A; St-Pierre S; Quirion R
    Synapse; 1996 Feb; 22(2):139-58. PubMed ID: 8787130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
    Dumont Y; Gaudreau P; Mazzuferi M; Langlois D; Chabot JG; Fournier A; Simonato M; Quirion R
    Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain.
    Dumont Y; Fournier A; Quirion R
    J Neurosci; 1998 Aug; 18(15):5565-74. PubMed ID: 9671648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
    Gehlert DR; Gackenheimer SL; Schober DA
    Neurochem Int; 1992 Jul; 21(1):45-67. PubMed ID: 1303142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain.
    Veyrat-Durebex C; Quirion R; Ferland G; Dumont Y; Gaudreau P
    Neuropeptides; 2013 Jun; 47(3):163-9. PubMed ID: 23410741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus.
    Jacques D; Dumont Y; Fournier A; Quirion R
    Neuroscience; 1997 Jul; 79(1):129-48. PubMed ID: 9178870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors.
    Gehlert DR; Schober DA; Gackenheimer SL; Beavers L; Gadski R; Lundell I; Larhammar D
    Peptides; 1997; 18(3):397-401. PubMed ID: 9145427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand association with the rabbit kidney and brain Y1, Y2 and Y5-like neuropeptide Y (NPY) receptors shows large subtype-related differences in sensitivity to chaotropic and alkylating agents.
    Parker SL; Parker MS
    Regul Pept; 2000 Feb; 87(1-3):59-72. PubMed ID: 10710289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the existence of an additional class of neuropeptide Y receptor sites in rat brain.
    Dumont Y; Moyse E; Fournier A; Quirion R
    J Pharmacol Exp Ther; 2005 Oct; 315(1):99-108. PubMed ID: 15947033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.